Page last updated: 2024-10-29

iopromide and Cancer of the Thyroid

iopromide has been researched along with Cancer of the Thyroid in 2 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yeom, JA1
Roh, J1
Jeong, YJ1
Lee, JC1
Kim, HY1
Suh, YJ1
Baik, SK1
Choi, JS1
Kim, J1
Kwak, JY1
Kim, MJ1
Chang, HS1
Kim, EK1

Trials

1 trial available for iopromide and Cancer of the Thyroid

ArticleYear
Ultra-Low-Dose Neck CT With Low-Dose Contrast Material for Preoperative Staging of Thyroid Cancer: Image Quality and Diagnostic Performance.
    AJR. American journal of roentgenology, 2019, Volume: 212, Issue:4

    Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Neoplasm Staging; Radiation

2019

Other Studies

1 other study available for iopromide and Cancer of the Thyroid

ArticleYear
Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:3

    Topics: Adult; Aged; Carcinoma, Papillary; Chi-Square Distribution; Contrast Media; Female; Humans; Image In

2009